Rxivist logo

Author: Sivan Gazit

  • ORCiD: http://orcid.org/0000-0001-9875-3550
  • Most recently observed institution: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.

Rankings

  • All-time downloads: 1,331,341 (rank: 11 )
  • Categories:
    • epidemiology: 125,066 (rank: 180 (tie) )
    • health policy: 986 (rank: 685 (tie) )
    • infectious diseases: 1,167,246 (rank: 2 )

Downloads per author, site-wide

Preprints

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

infectious diseases more details view paper
  • Downloaded 972,979 times
  • Download rankings, all-time:
    • Site-wide: 2
    • In infectious diseases: 1
  • Year to date:
    • Site-wide: 7
  • Since beginning of last month:
    • Site-wide: 15

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study

epidemiology more details view paper
  • Downloaded 124,178 times
  • Download rankings, all-time:
    • Site-wide: 53
    • In epidemiology: 12
  • Year to date:
    • Site-wide: 483
  • Since beginning of last month:
    • Site-wide: 471

Decreased SARS-CoV-2 viral load following vaccination

infectious diseases more details view paper
  • Downloaded 93,351 times
  • Download rankings, all-time:
    • Site-wide: 87
    • In infectious diseases: 31
  • Year to date:
    • Site-wide: 660
  • Since beginning of last month:
    • Site-wide: 983

The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence

infectious diseases more details view paper
  • Downloaded 45,866 times
  • Download rankings, all-time:
    • Site-wide: 202
    • In infectious diseases: 76
  • Year to date:
    • Site-wide: 6,729
  • Since beginning of last month:
    • Site-wide: 16,289

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine

infectious diseases more details view paper
  • Downloaded 22,888 times
  • Download rankings, all-time:
    • Site-wide: 463
    • In infectious diseases: 177
  • Year to date:
    • Site-wide: 501
  • Since beginning of last month:
    • Site-wide: 6,278

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine

infectious diseases more details view paper
  • Downloaded 14,078 times
  • Download rankings, all-time:
    • Site-wide: 830
    • In infectious diseases: 283
  • Year to date:
    • Site-wide: 1,899
  • Since beginning of last month:
    • Site-wide: 16,358

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities at daily resolution

infectious diseases more details view paper
  • Downloaded 12,530 times
  • Download rankings, all-time:
    • Site-wide: 963
    • In infectious diseases: 314
  • Year to date:
    • Site-wide: 4,260
  • Since beginning of last month:
    • Site-wide: 7,636

SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates

infectious diseases more details view paper
  • Downloaded 10,062 times
  • Download rankings, all-time:
    • Site-wide: 1,269
    • In infectious diseases: 400
  • Year to date:
    • Site-wide: 7,055
  • Since beginning of last month:
    • Site-wide: 4,139

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

infectious diseases more details view paper
  • Downloaded 9,898 times
  • Download rankings, all-time:
    • Site-wide: 1,293
    • In infectious diseases: 409
  • Year to date:
    • Site-wide: 1,901
  • Since beginning of last month:
    • Site-wide: 24,825

Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

public and global health more details view paper
  • Downloaded 4,965 times
  • Download rankings, all-time:
    • Site-wide: 3,214
    • In public and global health: None
  • Year to date:
    • Site-wide: 206
  • Since beginning of last month:
    • Site-wide: 537

A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report

infectious diseases more details view paper
  • Downloaded 4,294 times
  • Download rankings, all-time:
    • Site-wide: 3,910
    • In infectious diseases: 989
  • Year to date:
    • Site-wide: 1,847
  • Since beginning of last month:
    • Site-wide: 2,942

Waning of SARS-CoV-2 booster viral-load reduction effectiveness

infectious diseases more details view paper
  • Downloaded 4,052 times
  • Download rankings, all-time:
    • Site-wide: 4,242
    • In infectious diseases: 922
  • Year to date:
    • Site-wide: 408
  • Since beginning of last month:
    • Site-wide: 36,486

Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose

infectious diseases more details view paper
  • Downloaded 2,358 times
  • Download rankings, all-time:
    • Site-wide: 9,338
    • In infectious diseases: 1,790
  • Year to date:
    • Site-wide: 2,870
  • Since beginning of last month:
    • Site-wide: 6,190

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents

epidemiology more details view paper
  • Downloaded 2,124 times
  • Download rankings, all-time:
    • Site-wide: 10,922
    • In epidemiology: 958
  • Year to date:
    • Site-wide: 625
  • Since beginning of last month:
    • Site-wide: 18,702

Waning Effectiveness of the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine

public and global health more details view paper
  • Downloaded 2,020 times
  • Download rankings, all-time:
    • Site-wide: 11,782
    • In public and global health: None
  • Year to date:
    • Site-wide: 680
  • Since beginning of last month:
    • Site-wide: 10,065

Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents

public and global health more details view paper
  • Downloaded 1,205 times
  • Download rankings, all-time:
    • Site-wide: 25,939
    • In public and global health: None
  • Year to date:
    • Site-wide: 1,355
  • Since beginning of last month:
    • Site-wide: 65

Survey of Behaviour Attitudes Towards Preventive Measures Following COVID-19 Vaccination

health policy more details view paper
  • Downloaded 1,169 times
  • Download rankings, all-time:
    • Site-wide: 27,097
    • In health policy: 98
  • Year to date:
    • Site-wide: 12,379
  • Since beginning of last month:
    • Site-wide: 5,297

BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients

infectious diseases more details view paper
  • Downloaded 1,167 times
  • Download rankings, all-time:
    • Site-wide: 27,197
    • In infectious diseases: 2,566
  • Year to date:
    • Site-wide: 35,163
  • Since beginning of last month:
    • Site-wide: 83,024

Kinetics of SARS-CoV-2 anti-s IgG after BNT162b2 vaccination

infectious diseases more details view paper
  • Downloaded 1,104 times
  • Download rankings, all-time:
    • Site-wide: 29,584
    • In infectious diseases: 2,726
  • Year to date:
    • Site-wide: 53,489
  • Since beginning of last month:
    • Site-wide: 12,548

Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine

infectious diseases more details view paper
  • Downloaded 482 times
  • Download rankings, all-time:
    • Site-wide: 92,469
    • In infectious diseases: None
  • Year to date:
    • Site-wide: 5,661
  • Since beginning of last month:
    • Site-wide: 260

A Multilayer Model for Early Detection of COVID-19

infectious diseases more details view paper
  • Downloaded 335 times
  • Download rankings, all-time:
    • Site-wide: 129,201
    • In infectious diseases: 6,095
  • Year to date:
    • Site-wide: 56,870
  • Since beginning of last month:
    • Site-wide: 13,344

Immunosuppression as a hub for SARS-CoV-2 mutational drift

epidemiology more details view paper
  • Downloaded 236 times
  • Download rankings, all-time:
    • Site-wide: 158,466
    • In epidemiology: None
  • Year to date:
    • Site-wide: 16,857
  • Since beginning of last month:
    • Site-wide: 820

PanLingua

News